uracil and Peritonitis
uracil has been researched along with Peritonitis in 10 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of advanced gastric cancers with peritonitis carcinomatosa is very difficult, because none of the various therapies (operation, chemotherapy, hyperthermia etc." | 1.32 | [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites]. ( Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M, 2004) |
| "One of the breast cancer patients introduced here suffered from recurrent carcinomatous pleurisy and the other from recurrent carcinomatous peritonitis." | 1.31 | [Improved QOL with cancer chemotherapy in two patients with breast cancer suffering form carcinomatous pleurisy and carcinomatous peritonitis]. ( Fujitomi, Y; Fujiyoshi, K; Yasue, K, 2000) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chestnova, TV | 1 |
| Zilov, VG | 1 |
| Gladkikh, PG | 1 |
| Khadartsev, AA | 1 |
| Korotkova, AS | 1 |
| Buzulukov, YP | 1 |
| Arseniuk, VV | 1 |
| Bartosh, AM | 1 |
| Vasul'ianov, DS | 1 |
| Voĭtenko, II | 1 |
| Hryniv, OV | 1 |
| Smotrov, MI | 1 |
| Nakamura, T | 1 |
| Shimada, K | 1 |
| Okubo, Y | 1 |
| Tanaka, S | 1 |
| Tanabe, S | 2 |
| Yoshida, M | 1 |
| Doi, K | 1 |
| Uchinami, M | 1 |
| Horiuchi, T | 1 |
| Tanaka, K | 1 |
| Babadzhanov, BD | 1 |
| Teshaev, OR | 1 |
| Torba, AV | 1 |
| Takayanagi, N | 1 |
| Danjo, Y | 1 |
| Fujitomi, Y | 1 |
| Fujiyoshi, K | 1 |
| Yasue, K | 1 |
| Hasegawa, Y | 1 |
| Honnma, S | 1 |
| Takanashi, K | 1 |
| Yajima, K | 1 |
| Nakashima, Y | 1 |
| Seki, H | 1 |
| Takahashi, H | 1 |
| Kimura, K | 1 |
| Ishibashi, H | 1 |
| Hirakawa, K | 1 |
| Nakajima, H | 1 |
| Ioka, J | 1 |
| Shirono, K | 1 |
| Ochiai, K | 1 |
| Tomita, K | 1 |
| Kitagawa, Y | 1 |
Other Studies
10 other studies available for uracil and Peritonitis
| Article | Year |
|---|---|
Combined Effect of Silver Nanoparticles, Ceftriaxone, and Methyluracil during Experimental Purulent Peritonitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Infectious Disease Medicine; Inflammation; Ma | 2018 |
[Probability of incidence of abdominal adhesional process in peritonitis, depending on the sanation preparation applied].
Topics: Anti-Infective Agents, Local; Appendicitis; Chloramphenicol; Decamethonium Compounds; Drug Combinati | 2014 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administrati | 2004 |
[Improvement of curative measures for peritonites of obstetric and gynecological etiology].
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Catheterization; Chlorampheni | 2004 |
[Application of photochemically activated ointment based on polyethylene oxides for treatment of peritonitis].
Topics: Animals; Anti-Infective Agents, Local; Chloramphenicol; Chlorhexidine; Disease Models, Animal; Drain | 2005 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract | 1998 |
[Improved QOL with cancer chemotherapy in two patients with breast cancer suffering form carcinomatous pleurisy and carcinomatous peritonitis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubic | 2000 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
[Concentration of 5-FU and tegafur in the ascites fluid in patients with peritonitis carcinomatosa after UFT oral administration].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Fluorouracil; G | 1987 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1987 |